Gabapentin classification
Pro Research Analysisby 
Searched over 200M research papers for "gabapentin classification"
Gabapentin Drug Classification and Regulatory Status
Gabapentin is primarily classified as an antiepileptic (anticonvulsant) medication and is also widely used for neuropathic pain management and, less commonly, for certain movement disorders such as dystonia in children 356. Its mechanism of action involves binding to the α2δ subunit of voltage-dependent calcium channels, which distinguishes it as a novel class of selective antihyperalgesic agents .
Controlled Substance Status and Abuse Potential
Gabapentin was initially considered to have no significant abuse potential, leading to its widespread off-label use. However, increasing evidence has shown that gabapentin can be misused, especially among individuals with a history of substance abuse or mental illness 24. Misuse is often for recreational purposes, self-medication, or to enhance the effects of other substances such as opioids, benzodiazepines, or alcohol 24. The prevalence of misuse is particularly high among people who abuse opioids .
Due to these concerns, several regions have reclassified gabapentin as a controlled substance. For example, the United Kingdom reclassified gabapentin as a Class C controlled substance in 2019, requiring stricter prescription controls . In the United States, some states have designated gabapentin as a Schedule V controlled substance and have implemented prescription monitoring programs to track its use .
Clinical Implications and International Classification
The move to classify gabapentin as a controlled substance is driven by the need to address rising rates of misuse, abuse, and associated deaths 12. These regulatory changes aim to enhance patient safety and reduce the risk of diversion and abuse, especially among high-risk populations 124.
Conclusion
Gabapentin is classified as an antiepileptic and analgesic medication, but due to its potential for misuse and abuse, it has been reclassified as a controlled substance in several regions. This reclassification reflects growing concerns about its abuse potential and the need for tighter regulation to protect public health 124.
Sources and full results
Most relevant research papers on this topic